Complete Filing Data
Compass Therapeutics, Inc. reported Stockholders Equity of $196.79 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Compass Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$66.5M | -$49.4M | -$42.5M | -$39.2M | -$82.2M | -$29.5M | -$34.7M | -$35.1K |
| Operating Income Loss | -$72.8M | -$56.6M | -$50.4M | -$41.7M | -$81.9M | -$27.8M | -$34.1M | -$35.0K |
| General And Administrative Expense | $16.9M | $15.1M | $12.2M | $11.7M | $10.9M | $12.9M | $11.6M | $35.0K |
| Operating Expenses | $72.8M | $57.5M | $50.4M | $41.7M | $81.9M | $27.8M | $34.1M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$42.5M | -$39.2M | -$82.2M | -$29.5M | -$34.7M | |||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $32.0K | $91.0K | |||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $70.0K | $173.0K | $339.0K | -$302.0K | $0.00 | |||
| Other Nonoperating Income Expense | $6.4M | $7.3M | $7.9M | $2.4M | -$299.0K | -$1.7M | $627.0K | |
| Research And Development Expense Excluding Acquired In Process Cost | $56.0M | $42.3M | $38.1M | $30.0M | $20.3M | $14.9M | ||
| Interest Expense | $908.0K | $1.2M | $52.00 | |||||
| Comprehensive Income Net Of Tax | -$66.4M | -$49.2M | -$42.2M | -$39.5M | -$82.2M | |||
| Research And Development Expense | $14.9M | $22.4M | ||||||
| Nonoperating Income Expense | -$1.7M | -$601.0K | ||||||
| Non Cash Interest Expense | $41.0K | $90.0K | $116.0K | |||||
| Revenue From Contract With Customer Including Assessed Tax | $0.00 | $850.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$14.3M | -$19.9M | -$16.6M | -$10.5M | -$13.1M | -$10.8M | -$10.0M | -$11.3M | -$7.8M | -$12.0M | -$8.5M | -$7.2M | -$6.0M | -$55.8M | -$7.4M | -$9.2M | -$5.6M | -$6.4M | -$11.7K | -$8.6M | -$8.8M | -$10.8M | -$10.1K | -$8.6K | -$8.5K |
| Operating Income Loss | -$15.8M | -$21.1M | -$18.0M | -$12.2M | -$15.0M | -$12.8M | -$11.9M | -$13.3M | -$9.7M | -$12.6M | -$9.0M | -$7.2M | -$5.9M | -$55.7M | -$7.3M | -$9.0M | -$5.1M | -$5.8M | -$10.2K | -$8.4M | -$8.7M | -$9.3K | -$7.8K | -$7.9K | |
| General And Administrative Expense | $3.0M | $4.7M | $4.9M | $3.6M | $4.7M | $3.2M | $3.1M | $3.1M | $3.1M | $2.8M | $3.1M | $2.8M | $2.7M | $2.2M | $2.6M | $5.3M | $2.1M | $2.3M | $10.2K | $2.4M | $3.3M | $9.3K | $7.8K | $7.9K | |
| Operating Expenses | $15.8M | $21.1M | $18.0M | $12.2M | $15.9M | $12.8M | $11.9M | $13.3M | $9.7M | $12.6M | $9.0M | $7.2M | $5.9M | $55.7M | $7.3M | $9.0M | $5.1M | $5.8M | $8.4M | $8.7M | |||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$16.6M | -$13.1M | -$10.8M | -$10.0M | -$11.3M | -$7.8M | -$12.0M | -$8.5M | -$7.2M | -$6.0M | -$55.8M | -$7.4M | -$9.2M | -$5.5M | -$6.4M | -$8.5M | -$8.8M | ||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $13.0K | $0.00 | $0.00 | $16.0K | $16.0K | $26.0K | $26.0K | ||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $66.0K | $18.0K | -$20.0K | $577.0K | -$1.0K | -$127.0K | $77.0K | -$361.0K | $156.0K | -$129.0K | -$512.0K | $0.00 | $0.00 | $0.00 | |||||||||||
| Other Nonoperating Income Expense | $1.6M | $1.2M | $1.3M | $1.8M | $2.0M | $2.0M | $2.0M | $2.1M | $1.9M | $623.0K | $493.0K | $20.0K | -$121.0K | -$102.0K | -$83.0K | -$189.0K | -$471.0K | -$555.0K | |||||||
| Research And Development Expense Excluding Acquired In Process Cost | $12.8M | $16.4M | $13.1M | $8.6M | $11.2M | $9.5M | $8.8M | $10.2M | $6.6M | $9.8M | $5.9M | $4.4M | $3.2M | $2.9M | $4.7M | $3.7M | $3.0M | ||||||||
| Interest Expense | $212.0K | $242.0K | $1.4K | $312.0K | $314.0K | $875.00 | $771.00 | $580.00 | |||||||||||||||||
| Comprehensive Income Net Of Tax | -$14.2M | -$19.9M | -$16.7M | -$9.9M | -$13.1M | -$10.9M | -$9.9M | -$11.6M | -$7.7M | -$12.1M | -$9.0M | -$7.2M | -$6.0M | -$55.8M | |||||||||||
| Research And Development Expense | $4.7M | $3.7M | $3.0M | $3.6M | $6.0M | $5.4M | |||||||||||||||||||
| Nonoperating Income Expense | -$189.0K | -$471.0K | -$143.0K | -$110.0K | |||||||||||||||||||||
| Non Cash Interest Expense | $0.00 | $15.0K | $26.0K | ||||||||||||||||||||||
| Revenue From Contract With Customer Including Assessed Tax | $0.00 | $0.00 | $0.00 | $850.0K | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $196.8M | $125.2M | $148.5M | $181.6M | $140.1M | $39.9M | $11.3M | -$84.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $31.2M | $44.1M | $24.2M | $34.9M | $144.5M | $47.3M | $25.6M | $57.8M |
| Cash And Cash Equivalents At Carrying Value | $30.6M | $43.5M | $24.2M | $34.9M | $144.5M | $47.1M | $25.3M | |
| Retained Earnings Accumulated Deficit | -$431.2M | -$364.7M | -$315.3M | -$272.8M | -$233.6M | -$151.4M | -$121.9M | -$35.1K |
| Liabilities Current | $14.0M | $8.9M | $7.8M | $16.2M | $10.6M | $10.1M | $9.8M | $34.6K |
| Liabilities And Stockholders Equity | $219.6M | $140.4M | $156.9M | $199.6M | $153.8M | $51.9M | $30.4M | $25.00 |
| Liabilities | $22.8M | $15.2M | $8.3M | $18.0M | $13.7M | $12.0M | $19.1M | $34.6K |
| Assets Current | $209.8M | $132.8M | $153.9M | $194.8M | $147.1M | $50.2M | $26.2M | $25.00 |
| Assets | $219.6M | $140.4M | $156.9M | $199.6M | $153.8M | $51.9M | $30.4M | $25.00 |
| Common Stock Value | $18.0K | $14.0K | $13.0K | $13.0K | $10.0K | $5.0K | $1.0K | $500.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$12.8M | $19.3M | -$10.7M | -$109.6M | $97.2M | $21.8M | -$32.2M | |
| Property Plant And Equipment Net | $102.0K | $353.0K | $898.0K | $1.6M | $2.2M | $1.1M | $3.8M | |
| Prepaid Expense And Other Assets Current | $913.0K | $6.0M | $1.4M | $8.2M | $2.6M | $3.1M | $935.0K | |
| Accrued Liabilities Current | $11.4M | $6.3M | $2.5M | $11.7M | $8.8M | $1.6M | $3.1M | |
| Accounts Payable Current | $1.6M | $2.2M | $4.1M | $3.4M | $867.0K | $1.1M | $629.0K | |
| Additional Paid In Capital Common Stock | $627.7M | $489.7M | $463.8M | $454.7M | $373.7M | $191.3M | $3.3M | |
| Other Assets Noncurrent | $568.0K | $320.0K | $320.0K | $320.0K | $320.0K | $129.0K | ||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | $70.0K | $42.0K | -$281.0K | $0.00 | |||
| Operating Lease Liability Noncurrent | $8.8M | $6.3M | $536.0K | $1.8M | $3.0M | $0.00 | ||
| Operating Lease Liability Current | $1.0M | $338.0K | $1.2M | $1.1M | $989.0K | $0.00 | ||
| Operating Lease Right Of Use Asset Amortization Expense | $1.2M | $1.2M | $1.2M | $1.1M | $1.1M | $0.00 | ||
| Operating Lease Right Of Use Asset | $9.1M | $6.7M | $1.8M | $3.0M | $4.1M | $0.00 | ||
| Marketable Securities Unrealized Gain Loss | $70.0K | $173.0K | -$339.0K | $302.0K | $0.00 | |||
| Marketable Securities Current | $178.3M | $83.2M | $128.2M | $151.7M | $0.00 | |||
| Marketable Securities Amortization Of Premium And Discount | -$1.7M | -$1.7M | -$3.2M | -$801.0K | $0.00 | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $280.0K | $210.0K | $37.0K | -$302.0K | $0.00 | |||
| Restricted Cash Noncurrent | $0.00 | $263.0K | $263.0K | |||||
| Long Term Debt Current | $0.00 | $7.5M | $5.6M | |||||
| Long Term Debt Noncurrent | $0.00 | $1.9M | $9.3M | |||||
| Repayments Of Debt | $0.00 | $9.4M | $5.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $209.6M | $93.2M | $110.3M | $138.4M | $146.1M | $157.1M | $160.0M | $168.3M | $175.3M | $116.1M | $126.9M | $134.5M | $23.9M | $28.9M | $33.5M | $47.3M | $53.3M | -$124.8M | -$112.2M | -$103.9M | -$95.3M | -$51.6K | -$43.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $46.8M | $23.4M | $41.6M | $37.4M | $19.4M | $24.0M | $30.4M | $19.3M | $27.0M | $16.5M | $26.2M | $136.4M | $25.7M | $31.4M | $39.8M | $55.8M | $65.6M | $17.8M | $31.3M | $38.1M | ||||
| Cash And Cash Equivalents At Carrying Value | $46.2M | $22.9M | $41.0M | $19.4M | $19.4M | $43.5M | $30.4M | $19.3M | $27.0M | $16.5M | $26.2M | $136.4M | $25.5M | $31.2M | $39.7M | $55.5M | $65.4M | $882.00 | $4.9K | $4.7K | $2.4K | $7.2K | ||
| Retained Earnings Accumulated Deficit | -$415.5M | -$401.2M | -$381.3M | -$349.7M | -$339.2M | -$326.1M | -$301.9M | -$291.9M | -$280.7M | -$261.2M | -$249.2M | -$240.8M | -$220.6M | -$214.6M | -$158.8M | -$143.0M | -$133.9M | -$91.0K | -$82.6K | -$62.2K | -$52.1K | -$43.5K | ||
| Liabilities Current | $12.4M | $13.9M | $14.9M | $4.4M | $9.5M | $3.9M | $9.1M | $9.7M | $11.2M | $9.6M | $10.9M | $9.3M | $7.7M | $8.4M | $10.9M | $9.7M | $11.6M | $91.3K | $86.9K | $66.4K | $54.0K | $50.3K | ||
| Liabilities And Stockholders Equity | $231.3M | $116.7M | $131.5M | $149.2M | $155.6M | $161.1M | $170.0M | $179.2M | $188.0M | $127.8M | $140.3M | $146.6M | $34.9M | $40.9M | $48.2M | $60.7M | $70.4M | $882.00 | $4.9K | $4.7K | $2.4K | $7.2K | ||
| Liabilities | $21.6M | $23.5M | $21.2M | $10.8M | $9.5M | $4.1M | $10.0M | $10.9M | $12.7M | $11.7M | $13.3M | $12.1M | $11.0M | $12.0M | $14.7M | $13.4M | $17.2M | $91.3K | $86.9K | $66.4K | $54.0K | $50.3K | ||
| Assets Current | $221.1M | $106.2M | $124.1M | $141.1M | $153.5M | $158.6M | $166.6M | $175.3M | $183.6M | $122.6M | $134.5M | $140.3M | $28.6M | $34.5M | $41.6M | $57.8M | $67.3M | $882.00 | $4.9K | $4.7K | $2.4K | $7.2K | ||
| Assets | $231.3M | $116.7M | $131.5M | $149.2M | $155.6M | $161.1M | $170.0M | $179.2M | $188.0M | $127.8M | $140.3M | $146.6M | $34.9M | $40.9M | $48.2M | $60.7M | $70.4M | $882.00 | $4.9K | $4.7K | $2.4K | $7.2K | ||
| Common Stock Value | $53.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | $10.0K | $10.0K | $10.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $500.00 | $500.00 | $500.00 | $500.00 | $500.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$2.4M | -$554.0K | -$7.9M | -$8.1M | -$7.5M | -$7.8M | ||||||||||||||||||
| Property Plant And Equipment Net | $119.0K | $131.0K | $231.0K | $493.0K | $592.0K | $744.0K | $1.1M | $1.2M | $1.4M | $1.7M | $1.9M | $2.1M | $1.4M | $1.2M | $1.2M | $2.4M | $2.8M | |||||||
| Prepaid Expense And Other Assets Current | $1.2M | $5.2M | $11.5M | $5.7M | $7.3M | $2.4M | $2.9M | $6.5M | $8.4M | $2.0M | $2.5M | $3.9M | $3.1M | $3.3M | $2.0M | $2.3M | $1.9M | |||||||
| Accrued Liabilities Current | $8.7M | $11.0M | $13.2M | $2.9M | $7.2M | $1.8M | $5.6M | $7.8M | $8.9M | $5.7M | $3.3M | $8.1M | $2.0M | $1.2M | $1.3M | $1.4M | $2.6M | |||||||
| Accounts Payable Current | $3.1M | $2.6M | $1.6M | $960.0K | $1.2M | $854.0K | $2.3M | $724.0K | $1.1M | $2.8M | $6.5M | $257.0K | $868.0K | $559.0K | $1.1M | $854.0K | $1.6M | |||||||
| Additional Paid In Capital Common Stock | $624.7M | $494.2M | $491.4M | $487.6M | $485.4M | $483.2M | $462.4M | $460.7M | $456.0M | $378.0M | $376.7M | $375.2M | $244.5M | $243.5M | $192.3M | $190.3M | $187.1M | |||||||
| Other Assets Noncurrent | $568.0K | $320.0K | $320.0K | $320.0K | $320.0K | $320.0K | $320.0K | $320.0K | $320.0K | $320.0K | $320.0K | $320.0K | $177.0K | $69.0K | ||||||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | $0.00 | -$1.3M | $0.00 | $69.0K | -$1.6M | $0.00 | $44.0K | ||||||||||||||||
| Operating Lease Liability Noncurrent | $9.6M | $6.3M | $6.3M | $0.00 | $189.0K | $869.0K | $1.2M | $1.5M | $2.1M | $2.4M | $2.7M | $3.3M | $3.6M | $3.9M | ||||||||||
| Operating Lease Liability Current | $271.0K | $109.0K | $557.0K | $1.1M | $1.2M | $1.2M | $1.1M | $1.1M | $1.1M | $1.1M | $1.0M | $1.1M | $1.0M | $1.0M | ||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $224.0K | $309.0K | $287.0K | $270.0K | $256.0K | |||||||||||||||||||
| Operating Lease Right Of Use Asset | $9.5M | $9.8M | $6.5M | $7.0M | $1.2M | $1.5M | $2.1M | $2.4M | $2.7M | $3.3M | $3.5M | $3.8M | $4.4M | $4.6M | $4.9M | |||||||||
| Marketable Securities Unrealized Gain Loss | -$20.0K | -$127.0K | $156.0K | $0.00 | ||||||||||||||||||||
| Marketable Securities Current | $173.7M | $78.1M | $71.6M | $98.6M | $126.8M | $132.6M | $133.3M | $149.5M | $148.1M | $104.1M | $105.8M | |||||||||||||
| Marketable Securities Amortization Of Premium And Discount | $26.0K | -$376.0K | -$593.0K | $0.00 | ||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $274.0K | $208.0K | $190.0K | $486.0K | -$91.0K | -$90.0K | -$430.0K | -$507.0K | -$146.0K | -$641.0K | -$512.0K | |||||||||||||
| Restricted Cash Noncurrent | $210.0K | $210.0K | $151.0K | $263.0K | $263.0K | |||||||||||||||||||
| Long Term Debt Current | $3.7M | $5.6M | $7.5M | $7.5M | $7.5M | |||||||||||||||||||
| Long Term Debt Noncurrent | $0.00 | $0.00 | $3.7M | $5.6M | ||||||||||||||||||||
| Repayments Of Debt | $0.00 | $1.9M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$49.1M | -$44.9M | -$40.6M | -$34.1M | -$19.7M | -$26.8M | -$31.7M | -$35.0K |
| Net Cash Provided By Used In Financing Activities | $129.6M | $17.3M | $2.9M | $75.8M | $118.6M | $48.5M | $37.6K | $35.0K |
| Net Cash Provided By Used In Investing Activities | -$93.3M | $46.8M | $27.0M | -$151.2M | -$1.8M | $38.0K | -$466.0K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$5.1M | $4.9M | -$6.8M | $5.6M | -$534.0K | $2.2M | -$435.0K | |
| Increase Decrease In Accrued Liabilities | $5.1M | $3.8M | -$9.2M | $2.9M | $7.0M | -$1.6M | $509.0K | |
| Increase Decrease In Accounts Payable | -$664.0K | -$1.8M | $708.0K | $2.5M | -$194.0K | $432.0K | -$1.1M | |
| Share Based Compensation | $8.4M | $8.6M | $6.1M | $5.3M | $4.0M | $4.0M | $915.0K | |
| Payments To Acquire Property Plant And Equipment | $25.0K | $44.0K | $30.0K | $212.0K | $1.6M | $106.0K | $466.0K | |
| Proceeds From Issuance Of Common Stock | $138.0M | $18.1M | $3.1M | $76.2M | $128.3M | $60.5M | $475.00 | |
| Stock Issued During Period Value Share Based Compensation | -$1.0M | -$232.0K | -$159.0K | $0.00 | $0.00 | |||
| Increase Decrease In Operating Lease Liability | -$369.0K | -$1.2M | -$1.2M | -$1.1M | -$1.1M | $0.00 | ||
| Payments Of Stock Issuance Costs | $8.6M | $543.0K | $94.0K | $495.0K | $281.0K | $6.3M | ||
| Payments To Acquire Marketable Securities | $194.6M | $88.2M | $155.4M | $200.1M | $0.00 | |||
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $176.0K | $116.0K | $144.0K | ||||
| Proceeds From Sale And Maturity Of Marketable Securities | $101.3M | $135.0M | $182.4M | $49.0M | $0.00 | |||
| Increase Decrease In Other Noncurrent Assets | $0.00 | $290.0K | $56.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q1 2020 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$13.2M | -$13.9M | -$12.2M | -$7.9M | -$5.6M | -$7.8M | -$7.9K | ||||||
| Net Cash Provided By Used In Financing Activities | -$815.0K | $17.4M | $41.0K | $0.00 | -$1.9M | $15.1K | |||||||
| Net Cash Provided By Used In Investing Activities | $11.6M | -$4.1M | $4.3M | -$193.0K | -$13.0K | -$12.0K | |||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $5.5M | $936.0K | $250.0K | $1.3M | -$1.2M | $24.0K | |||||||
| Increase Decrease In Accrued Liabilities | $6.9M | -$699.0K | -$2.7M | -$595.0K | -$442.0K | -$2.1M | |||||||
| Increase Decrease In Accounts Payable | -$672.0K | -$3.2M | -$2.3M | -$611.0K | $0.00 | -$285.0K | |||||||
| Share Based Compensation | $2.5M | $2.0M | $1.3M | $1.6M | $948.0K | $247.0K | |||||||
| Payments To Acquire Property Plant And Equipment | $18.0K | $0.00 | $0.00 | $194.0K | $128.0K | $12.0K | |||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $18.1M | $0.00 | ||||||||||
| Stock Issued During Period Value Share Based Compensation | -$815.0K | -$136.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Increase Decrease In Operating Lease Liability | -$253.0K | -$320.0K | -$293.0K | -$270.0K | -$246.0K | ||||||||
| Payments Of Stock Issuance Costs | $0.00 | $544.0K | $0.00 | ||||||||||
| Payments To Acquire Marketable Securities | $24.8M | $41.9M | $54.9M | $0.00 | |||||||||
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $1.0K | $115.0K | ||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $36.4M | $37.8M | $59.2M | $0.00 | |||||||||
| Increase Decrease In Other Noncurrent Assets | $34.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 50.0M |
| Common Stock Shares Outstanding | 178.3M | 137.8M | 127.7M | 126.3M | 100.8M | 51.2M | 7.0M | 5.0M |
| Common Stock Shares Issued | 178.3M | 137.8M | 127.7M | 126.5M | 101.3M | 52.1M | 9.1M | 5.0M |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 62.9M | 30.8M | 6.7M | 4.2M | ||||
| Earnings Per Share Basic And Diluted | $-1.31 | $-0.96 | $-5.19 | $-0.01 | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 5.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |||||
| Weighted Average Number Of Shares Outstanding Basic | 157.7M | 137.4M | 127.0M | 105.2M | 62.9M | |||
| Earnings Per Share Basic | $-0.42 | $-0.36 | $-0.33 | $-0.37 | $-1.31 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q4 2018 | Q3 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | ||||
| Common Stock Shares Outstanding | 177.6M | 138.3M | 138.3M | 137.6M | 137.6M | 137.6M | 127.4M | 127.4M | 126.4M | 101.0M | 101.0M | 100.9M | 61.8M | 61.7M | 51.3M | 51.0M | 50.9M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |||
| Common Stock Shares Issued | 177.6M | 138.3M | 138.3M | 137.6M | 137.6M | 137.6M | 127.5M | 127.5M | 126.5M | 101.3M | 101.3M | 101.3M | 62.3M | 62.3M | 52.1M | 52.1M | 52.2M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 100.9M | 61.7M | 51.9M | 51.3M | 50.9M | 13.6M | 7.1M | 5.0M | 6.8M | 6.6M | 5.0M | 5.0M | 5.0M | ||||||||||||
| Earnings Per Share Basic And Diluted | $-0.07 | $-0.10 | $-1.07 | $-0.14 | $-0.18 | $-0.41 | $-0.90 | $0.00 | $-1.27 | $-1.33 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 168.8M | 138.3M | 138.2M | 137.6M | 137.6M | 136.6M | 127.4M | 126.7M | 126.4M | 101.0M | 100.9M | 100.9M | 61.7M | 51.9M | |||||||||||
| Earnings Per Share Basic | $-0.08 | $-0.14 | $-0.12 | $-0.08 | $-0.10 | $-0.08 | $-0.08 | $-0.09 | $-0.06 | $-0.12 | $-0.08 | $-0.07 | $-0.10 | $-1.07 | |||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $8.4M | $8.6M | $6.1M | $5.3M | $4.0M | $4.0M | $915.0K | |
| Depreciation And Amortization | $276.0K | $589.0K | $699.0K | $782.0K | $566.0K | $2.4M | $2.1M | |
| Derivative Gain Loss On Derivative Net | $0.00 | -$556.0K | -$104.0K | |||||
| Interest Paid Net | $0.00 | $370.0K | $854.0K | $1.1M | ||||
| Stock Issued During Period Value New Issues | $129.4M | $17.6M | $3.0M | $75.7M | $128.0M | $54.2M | $500.00 | |
| Investment Income Interest | ||||||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $500.0K | $4.5M | $8.5M | $6.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.2M | $2.8M | $2.5M | $2.2M | $2.1M | $2.0M | $1.6M | $1.6M | $1.3M | $1.3M | $1.4M | $1.6M | $987.0K | $908.0K | $948.0K | $2.5M | $183.0K | $247.0K | $249.0K | $185.0K | $255.0K |
| Depreciation And Amortization | $140.0K | $154.0K | $194.0K | $165.0K | $157.0K | $463.0K | |||||||||||||||
| Derivative Gain Loss On Derivative Net | $0.00 | -$236.0K | -$320.0K | -$7.0K | -$32.0K | ||||||||||||||||
| Interest Paid Net | $0.00 | $137.0K | $256.0K | ||||||||||||||||||
| Stock Issued During Period Value New Issues | $129.4M | $17.6M | $3.0M | $53.6M | |||||||||||||||||
| Investment Income Interest | $22.0K | $7.0K | $176.0K | $237.0K | |||||||||||||||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $8.6M | $500.0K | $500.0K | $100.0K | $6.9M |
Most recent annual filing with the SEC: March 5, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.